Eastman Kodak
KODK
9.79
-0.08
-0.81%
Eastman Kodak
US · KODK
#3278 by market cap
9.79
-0.08
-0.81%
Live - 5344 symbols - heartbeat 305s ago
· 2026-10-08 09:20
Pre-market
9.58
-2.15%
After-hours
9.92
+1.33%
- Market cap
- 958.44M
- P/E (TTM)i
- -7.15
- P/Bi
- 1.54
- EPSi
- -1.78
- Div yieldi
- 0.00%
- 52W posi
- 44%
Reader sentiment
Are you bullish or bearish on KODK?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.01, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.49% YoY
Margins
- Gross margin
- 21.70%
- Operating margin
- -11.97%
- Net margin
- -14.50%
Key ratios & quality
- Enterprise valuei
- 840.44M
- Altman Z-Scorei
- 1.01
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.32B | 1.24B | 1.03B | 1.15B | 1.21B | 1.12B | 1.04B | 1.07B |
| Gross profit | 180.00M | 182.00M | 135.00M | 164.00M | 170.00M | 210.00M | 203.00M | 232.00M |
| Selling & admin expenses | 224.00M | 211.00M | 172.00M | 177.00M | 153.00M | 159.00M | 179.00M | 174.00M |
| Research & development | 48.00M | 42.00M | 34.00M | 33.00M | 34.00M | 34.00M | 33.00M | 33.00M |
| Operating profit | -101.00M | -66.00M | -64.00M | -46.00M | -16.00M | 16.00M | -11.00M | -128.00M |
| Pretax profit | -13.00M | -60.00M | -376.00M | 28.00M | 31.00M | 87.00M | 110.00M | -112.00M |
| Tax | -4.00M | 31.00M | 168.00M | 4.00M | 5.00M | 12.00M | 8.00M | 16.00M |
| Net profit | -16.00M | 116.00M | -541.00M | 24.00M | 26.00M | 75.00M | 102.00M | -128.00M |
| Basic EPS | -1 | 2 | -10 | 0 | 0 | 1 | 1 | -2 |
| Diluted EPS | -0.84 | 2.23 | -9.77 | 0.27 | 0.16 | 0.67 | 0.90 | -1.78 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 247.00M | 263.00M | 269.00M | 290.00M | 265.00M | 311.00M |
| Gross profit | 46.00M | 51.00M | 68.00M | 67.00M | 57.00M | 82.00M |
| Selling & admin expenses | 45.00M | 41.00M | 41.00M | 47.00M | 48.00M | 53.00M |
| Research & development | 9.00M | 9.00M | 7.00M | 8.00M | 8.00M | 9.00M |
| Operating profit | -8.00M | 1.00M | 20.00M | -141.00M | -1.00M | 20.00M |
| Pretax profit | -5.00M | -24.00M | 16.00M | -99.00M | -13.00M | 21.00M |
| Tax | 2.00M | 2.00M | 3.00M | 9.00M | 3.00M | 4.00M |
| Net profit | -7.00M | -26.00M | 13.00M | -108.00M | -16.00M | 17.00M |
| Basic EPS | 0 | 0 | 0 | -1 | 0 | 0 |
| Diluted EPS | -0.12 | -0.36 | -0.08 | -1.11 | -0.21 | 0.13 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 910.00M | 706.00M | 627.00M | 807.00M | 681.00M | 712.00M | 595.00M | 841.00M |
| Cash & ST investments | 233.00M | 233.00M | 196.00M | 362.00M | 217.00M | 255.00M | 201.00M | 337.00M |
| Inventory | 231.00M | 215.00M | 206.00M | 219.00M | 237.00M | 217.00M | 219.00M | 218.00M |
| Total assets | 1.51B | 1.42B | 1.25B | 2.17B | 2.29B | 2.36B | 2.00B | 1.62B |
| Total current liabilities | 778.00M | 368.00M | 296.00M | 309.00M | 293.00M | 283.00M | 261.00M | 268.00M |
| Short-term debt | 396.00M | 14.00M | 14.00M | 14.00M | 16.00M | 14.00M | 12.00M | 12.00M |
| Long-term debt | 2.00M | 105.00M | 14.00M | 252.00M | 315.00M | 456.00M | 465.00M | 207.00M |
| Total liabilities | 1,340,000,000.00 | 1,134,000,000.00 | 980,000,000.00 | 1,194,000,000.00 | 1,041,000,000.00 | 1,214,000,000.00 | 1,142,000,000.00 | 904,000,000.00 |
| Total equity | 170.00M | 281.00M | 268.00M | 977.00M | 1.24B | 1.14B | 859.00M | 713.00M |
| Retained earnings | -200.00M | -79.00M | -620.00M | -596.00M | -570.00M | -495.00M | -393.00M | -521.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 577.00M | 574.00M | 592.00M | 841.00M | 793.00M | 766.00M |
| Cash & ST investments | 158.00M | 155.00M | 168.00M | 337.00M | 299.00M | 290.00M |
| Inventory | 236.00M | 238.00M | 236.00M | 218.00M | 255.00M | 253.00M |
| Total assets | 1.94B | 1.93B | 2.08B | 1.62B | 1.56B | 1.53B |
| Total current liabilities | 261.00M | 729.00M | 749.00M | 268.00M | 314.00M | 263.00M |
| Short-term debt | 12.00M | 491.00M | 509.00M | 12.00M | 63.00M | 13.00M |
| Long-term debt | 473.00M | 11.00M | 10.00M | 207.00M | 108.00M | 108.00M |
| Total liabilities | 1,154,000,000.00 | 1,183,000,000.00 | 1,214,000,000.00 | 904,000,000.00 | 885,000,000.00 | 830,000,000.00 |
| Total equity | 783.00M | 750.00M | 861.00M | 713.00M | 672.00M | 697.00M |
| Retained earnings | -400.00M | -426.00M | -413.00M | -521.00M | -537.00M | -520.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -62.00M | 12.00M | -35.00M | -47.00M | -116.00M | 38.00M | -7.00M | 480.00M |
| Depreciation & amortization | 73.00M | 55.00M | 37.00M | 31.00M | 29.00M | 30.00M | 28.00M | 29.00M |
| Free cash flow | -95.00M | -3.00M | -52.00M | -68.00M | -147.00M | 6.00M | -63.00M | 446.00M |
| Dividends paid | -8.00M | -3.00M | -22.00M | -7.00M | -4.00M | -4.00M | -4.00M | -2.00M |
| Stock buybacks / issuance | -- | 0 | 0 | 9.00M | -1.00M | 0 | -1.00M | -6.00M |
| Ending cash balance | 267.00M | 290.00M | 256.00M | 423.00M | 286.00M | 377.00M | 301.00M | 442.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -38.00M | 8.00M | 21.00M | 489.00M | -30.00M | 5.00M |
| Depreciation & amortization | 7.00M | 7.00M | 7.00M | 8.00M | 7.00M | 6.00M |
| Free cash flow | -50.00M | -4.00M | 17.00M | 483.00M | -36.00M | 0 |
| Dividends paid | -1.00M | -1.00M | 0 | 0 | -3.00M | -1.00M |
| Stock buybacks / issuance | -1.00M | -1.00M | 1.00M | -5.00M | 0 | -2.00M |
| Ending cash balance | 256.00M | 253.00M | 271.00M | 442.00M | 399.00M | 388.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -133.33 | 200.00 | -637.50 | 5.13 | 1.43 | 5.68 | 9.92 | -24.70 |
| ROA %i | -2.24 | 6.56 | -42.13 | 1.29 | 0.58 | 2.41 | 3.58 | -8.57 |
| ROIC %i | -6.94 | 32.24 | -258.66 | 8.05 | 3.73 | 6.21 | 9.48 | -11.37 |
| 5-year avg ROE %i | -- | -- | -- | -- | -112.86 | -85.05 | -123.07 | -0.51 |
| EBIT margin %i | -0.30 | -3.54 | -35.37 | 5.30 | 5.89 | 12.44 | 16.20 | -4.68 |
| FCF / sales %i | -- | -- | -- | -- | -- | 0.54 | -- | 41.72 |
| Current ratioi | 1.17 | 1.92 | 2.12 | 2.61 | 2.32 | 2.52 | 2.28 | 3.14 |
| Quick ratioi | 0.60 | 1.20 | 1.26 | 1.74 | 1.34 | 1.59 | 1.30 | 1.80 |
| Debt / assetsi | 26.56 | 12.08 | 6.41 | 14.37 | 15.89 | 21.02 | 24.94 | 15.46 |
| LT debt / equityi | -- | 158.59 | 85.71 | 38.16 | 33.33 | 51.66 | 75.98 | 38.76 |
| Interest coveragei | -0.44 | -2.75 | -30.33 | 1.85 | 1.78 | 2.67 | 2.86 | -0.81 |
| Revenue CAGR (3Y) %i | -9.87 | -8.91 | -9.45 | -4.49 | -1.00 | 2.77 | -3.20 | -3.91 |
| Net income CAGR (3Y) %i | -- | 97.75 | -- | -- | -39.26 | -- | 61.98 | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 5.68 | -0.81 | -2.98 | -24.70 | -28.37 | -21.03 |
| ROA %i | 2.01 | -0.28 | -1.17 | -8.57 | -9.44 | -6.99 |
| ROIC %i | 6.87 | 2.67 | 1.08 | -11.37 | -14.89 | -11.11 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.30 | 7.43 | 7.27 | -4.68 | -6.07 | -2.64 |
| FCF / sales %i | -- | -- | -- | 41.72 | 42.32 | 40.88 |
| Current ratioi | 2.21 | 0.79 | 0.79 | 3.14 | 2.53 | 2.91 |
| Quick ratioi | 1.18 | 0.42 | 0.42 | 1.80 | 1.40 | 1.71 |
| Debt / assetsi | 26.28 | 27.63 | 26.46 | 15.46 | 12.72 | 9.69 |
| LT debt / equityi | 88.28 | 8.14 | 5.25 | 38.76 | 22.50 | 21.67 |
| Interest coveragei | 2.21 | 1.33 | 1.23 | -0.81 | -1.22 | -0.67 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Print is the largest reported line at 62.70% of revenue, across 4 reported segments.
- Advanced Materials and Chemicals follows at 33.76%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Print62.70%
Advanced Materials and Chemicals33.76%
Brand2.25%
All other revenues1.29%
Quote time 2026-10-08 09:20:24 · For reference only, not investment advice and not tailored to your situation.